Overall, our research has demonstrated that TRAF3 in OC cells is an immunosuppressive modulator that down-regulates MHC class I and IFN-I signaling, limits B-cell activation, and reduces the anti-tumor immunity of B cells. Here, TRAF3 is linked to neoplasm.